title: The molecular basis of haemophilia A and B.
abstract: Most families with haemophilia A or B carry gene defects of independent origin. Haemophilia B is mostly due to small changes in the factor IX gene affecting either its transcription, mRNA maturation, mRNA translation or the fine structure of factor IX. Only 2-3% of patients show gross deletions or rearrangements. The great variety of missense mutations reported to cause haemophilia B indicates that this multidomain protein is highly constrained. Less is known about the factor VIII gene as fully efficient mutation detection procedures only became available in 1991. This, however, led to the discovery that almost half the severe cases of haemophilia A or a fifth of all cases are due to frequently occurring inversions caused by homologous intra-chromosome (-chromatid) recombination between repeated sequences 9.5 kb long. Of the three repeats one is in intron 22 of the factor VIII gene and two are 400-500 kb more telomeric. They are 99.8% similar to each other. The spectrum of the other haemophilia A mutations is similar to that of haemophilia B. Since 1983 mounting evidence has shown that in both haemophilias the nature of the mutation is important in predisposing to the inhibitor complication.
authors.affiliation: Division of Medical & Molecular Genetics, United Medical School of Guy's, St Thomas's Hospitals, London, UK.?.
authors.forename: F
authors.initials: F
authors.lastname: Giannelli
authors.forename: P M
authors.initials: PM
authors.lastname: Green
mesh_terms: D000595:Amino Acid Sequence; D001323:Autoantibodies / Q000096:biosynthesis / Q000276:immunology; D007446:Chromosome Inversion; D004252:DNA Mutational Analysis; D005164:Factor IX / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use; D005169:Factor VIII / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use; D005786:Gene Expression Regulation; D005796:Genes; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D002836:Hemophilia B / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000096:biosynthesis / Q000276:immunology; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D012326:RNA Splicing; D017384:Sequence Deletion
chemical_list: D001323:Autoantibodies; D007518:Isoantibodies; D011498:Protein Precursors; D005169:Factor VIII; D005164:Factor IX